Metacarpophalangeal joint synovial pad fibrotic proliferation in 63 horses.
Medical records, radiographs, and sonograms of 63 horses with metacarpophalangeal joint synovial pad proliferation were examined retrospectively. All horses had lameness, joint effusion, or both signs associated with one or both metacarpophalangeal joints. Bony remodeling and concavity of the distodorsal aspect of the third metacarpal bone (Mc3) just proximal to the metacarpal condyles was identified by radiography in 71 joints (93%); 24 joints (32%) had radiographic evidence of a chip fracture located at the proximal dorsal aspect of the proximal phalanx. Fifty-four joints (71%) were examined by ultrasound. The mean +/- SD sagittal thickness of the synovial pad was 11.3 +/- 2.8 mm. Seventy-nine percent of the horses had single joint involvement with equal distribution, between the right and left forelimbs. Sixty-eight joints in 55 horses were treated by arthroscopic surgery. Sixty joints (88%) had debridement of chondral or osteochondral fragmentation from the dorsal surface of Mc3 beneath the synovial pad and 30 joints (44%) had a bone chip fracture removed from the medial or lateral proximal dorsal eminence of the proximal phalanx. Complete or partial excision of both medial and lateral synovial pads was completed in 42 joints. Only the medial synovial pad was excised or trimmed in 21 joints, and 5 joints had only the lateral pad removed. Eight joints in eight horses were treated by stall rest, administration of intra-articular medication and systemic nonsteroidal anti-inflammatory drugs. Follow-up information was obtained for 50 horses treated surgically and for eight horses treated medically. Forty-three (86%) that had surgery returned to racing; 34 (68%) raced at an equivalent or better level than before surgery. Three (38%) of the medically treated horses returned to racing; only one horse raced better than the preinjury level. Horses that returned to racing at a similar or equal level of performance were significantly younger in age than horses returning at a lower level or not racing (P < or = .05). Overall, horses with synovial pad proliferation treated by arthroscopic surgery had a good prognosis for return to racing at a level equal or better than before injury.
Dabareiner
R M
RM
Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic and State University, Leesburg, VA, USA.
White
N A
NA
Sullins
K E
KE
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001182:Arthroscopy / Q000662:veterinary; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D006734:Horse Diseases / Q000473:pathology* / Q000503:physiopathology / Q000628:therapy; D006736:Horses / Q000502:physiology*; D007794:Lameness, Animal / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D011379:Prognosis; D011859:Radiography; D012189:Retrospective Studies; D012420:Running / Q000502:physiology; D013522:Surgery, Veterinary / Q000379:methods; D013583:Synovial Membrane / Q000187:drug effects / Q000473:pathology* / Q000502:physiology; D014033:Toe Joint / Q000000981:diagnostic imaging / Q000473:pathology*; D016896:Treatment Outcome; D014463:Ultrasonography
D000894:Anti-Inflammatory Agents, Non-Steroidal